The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review
Keywords: pediatric obesity, GLP-1 receptor agonists, semaglutide, adolescent weight management, pharmacotherapy, long-term safety, health equity, obesity treatment Introduction The global pediatric obesity epidemic represents one of the most pressing public health challenges of the 21st century
Specialist Support: You have 24/7 access to our team to answer questions about storage, side effects, or dosing
However, when analyzing the overall effects across daytime and nighttime (Supplemental Table S1), both VSG and semaglutide treatments significantly reduced total EE and active EE, with no difference between the two treatments (Supplemental Table S1)